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Abstract Invading pathogens are recognized by mammalian
cells through dedicated receptors found either at the cell
surface or in the cytoplasm. These receptors, like the trans-
membrane Toll-like Receptors (TLR) or the cytosolic Nod-like
Receptors (NLR), initiate innate immunity after recognition of
molecular patterns found in bacteria or viruses, such as LPS,
flagellin, or double-stranded RNA. Recognition of molecules
produced only by a specific pathogen, such as a viral envelop
protein or a bacterial adhesin does not appear to occur.
Bacterial protein toxins, however, might compose an interme-
diate class. Considering the diversity of toxins in terms of
structure, it is unlikely that cells respond to them via specific
molecular recognition. It rather appears that different classes of
toxins trigger cellular changes that are sensed by the cells as
danger signals, such as changes in cellular ion composition
after membrane perforation by pore-forming toxins or type III
secretion systems. The signaling pathways triggered through
toxin-induced cell alterations will likely play a role in
modulating host responses to virulent bacteria. We will here
describe the few studied cases in which detection of the toxin
by the host cell was addressed. The review will include not
only toxins but also bacteria effectors secreted by the
bacterium in to the host cell cytoplasm.
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During infection, pathogenic microbes actively modify the
behavior of host cells to allow them to withstand the rigors
of the host environment and establish a suitable replication
niche. Changes in host cell properties and behavior include
modification of plasma membrane permeability, induction,
or inhibition of phagocytosis or apoptosis, depending on
the pathogen and the host cell type. These changes result
from the action of bacterial proteins that have either
membrane interacting activity (pore-forming toxins or
PFTs, lipases) or an enzymatic activity (protease, phosphatase,
ubiquitin ligase, glucosidase, ADP ribosyltransferase, ...)
[4, 16, 50]. These activity-bearing bacterial proteins are
either secreted into the extracellular medium and called
exotoxins or toxins, or they can be injected into the host cell
cytoplasm through specialized bacterial secretion machin-
eries and are then called effectors. In this review we will use
the term toxin in its largest sense including both exotoxins
and effectors.
Toxins are produced by many bacterial pathogens,
whether gram positive or negative, and contribute to, and
are sometimes essential for, virulence. Efforts over the last
decades have been focused on determining the activity and
targets of toxins and how these toxins affect host cell
function and behavior. More recently, a novel concern has
appeared in the cellular microbiology field, which is to
understand whether cells sense the presence or effects of
toxins and whether they mount a response, even in the case
of nonimmune cells. After a brief introduction on toxins
and the mode of delivery of bacterial proteins into the
mammalian cytoplasm, we will discuss recent findings that
indicate that the effects of toxins can be sensed and that a
response is mounted that depends on the nature and
amplitude of the toxic insult as well as the type of affected
cell.
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The bacterial toolkit
Bacterial toxins and effectors are generally either enzymes
or pore-forming proteins, notable exceptions are the so-
called super-antigens, which induce massive unspecific
T-cell activation [4]. Note that many pathogenic bacteria
will produce more than one toxin and for those harboring a
type 3 secretion system (T3SS), always multiple effectors,
sometimes near to 20 different ones [72]. While novel
enzymatic activities are continuously reported, the list of
characterized activities is already extremely long (Table 1),
including activities as diverse as ADP-ribosyltransferase
such as cholera toxin [39], phosphatidyl inositol-4,
5-phosphatase as Salmonella SopB [30], MAP kinase
kinases acetylase as Yersinia YopJ [52], and MAP kinase
phosphatase as Shigella OspF [6].
Pore-forming toxins
In the context of this review, an important class of toxins is that
of pore-forming toxins, which compose approximately a third
of all characterized bacterial toxins and are produced by both
Gram-positive and Gram-negative bacteria [7, 55]. Most PFTs
share the following mode of action: they are released by the
bacteria in a soluble, generally monomeric, form that freely
diffuses towards target cells. Host cell binding occurs by
specific interactions with cell surface molecules that can be
either lipids, such as for Listeria monocytogenes listeriolysin
O (LLO) or Bacillus thuringiensis crystal toxin; proteins,
such as for Streptoccus intermedius Intermedilysin or
carbohydrates bound to proteins, such as for Aeromonas
hydrophila aerolysin [7, 23]. Once bound to its receptor, the
toxin undergoes circular polymerization into ring-like struc-
tures, the stoichiometry of which varies amongst toxins. The
amphipathic nature of these complexes leads to spontaneous
insertion into the membrane. Depending on the toxin, the pore
diameter varies from 1 up to 50 nm [7, 55]. PFTs are generally
produced by bacteria that remain extracellular, and thus pore-
formation occurs at the plasma membrane. Some bacteria that
replicate intracellularly, such as L. monocytogenes and Group
A Streptococci, however, also produce PFTs, listeriolysin O
(LLO), and streptolysin O (SLO), respectively. Although
LLO will form pores in the plasma membrane upon secretion
by extracellular Listeria, it is absolutely required for the
bacterium to breach the phagosomal membrane allowing
escape into the cytoplasm [16].
Delivery of bacterial proteins into the host cell
cytoplasm
Except for lipases, the targets of all the bacterial toxins with
enzymatic activity mentioned above reside in the host
cytoplasm. Thus the first challenge of these molecules is to
get across the plasma membrane, an event that is impossible
for a soluble protein if not assisted. Evolution has led to two
strategies that will be detailed below: (1) the development of a
bacterial injection system that brings the enzyme directly from
the bacterial cytoplasm to that of the host, (2) the production of
a pore-forming protein that escorts the enzyme to the
cytoplasm, mediating both host cell recognition and transloca-
tion of the enzyme across membranes.
Type III and IV secretion machineries
Some Gram-negative bacteria inject their toxins into the
cytosol of host cells through bacterial transport machines
that function as macromolecular syringes [50]. The best
characterized is the type III secretion system (T3SS). T3SSs
consist of three parts: a cytoplasmic bulb, a region spanning
both the inner and the outer bacterial membranes, and a
hollow ‘needle’ protruding from the bacterial surface. The
needle is involved in sensing the presence of host cells and
triggers the so-called contact mediated secretion, via
mechanisms that remain unclear. Transport of effectors is
thought to proceed through the central 25-Å channel of the
needle. Access to the host cytoplasm, however, also
requires perforation of the eukaryotic plasma membrane.
This occurs through the secretion of early effectors such as
IpaB for Shigella flexneri or SipB for Salmonella that have
a pore-forming capacity and puncture the membrane at the
tip of the secretion needle, thus creating a continuous
conduit from the bacterial cytoplasm to that of the host.
This secretion machinery is thought to have evolved from
the flagellar export system.
Whereas T3SSs are the most widely spread secretion
systems amongst pathogenic bacteria, some Gram-negative
bacteria express a somewhat different secretion apparatus
termed the Type IV secretion system (T4SSs) [18]. T4SSs
were first identified in plant pathogens but have since been
identified in Legionella or Brucella, for which they are
crucial to establish infection. The interesting additional
property of T4SSs is that they have been shown to transport
DNA, in addition to proteins, during infection of plants.
Injection of bacterial DNA into mammalian cells has not
been documented. Please note that type III and IV secretion
systems are solely devoted to introducing bacterial proteins
in the host cell cytoplasm. Bacterial secretion of exotoxins
such as pore-forming toxins relies on other secretion
apparatuses such as type I and type II secretion systems.
Needle type injection machineries have not been found
in Gram-positive bacteria. It has, however, been shown that
Streptococcus pyogenes utilizes a Cytolysin-mediated
translocation (CMT) to introduce an effector protein of
streptococcal origin into the cytoplasm of a host cell [40].
S. pyogenes produces the pore-forming toxin SLO that
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makes large pores which allow the passage of proteins. It
was found that the S. pyogenes NAD-glycohydrolase
involved in virulence is translocated into the host cell via
the SLO pore. The model proposes that translocation,
which might involve contact between the bacterium and the
host, is coupled to polarized secretion, as is supported by
the fascinating observation that S. pyogenes has a special-
ized microdomain in its plasma membrane, positioned at a
hemispherical position distal to either cell pole, termed the
ExPortal, which contains the Sec translocons [63].
AB type toxins
Toxins of the AB type are composed either of multiple
domains or multiple independent polypeptides. The A
subunit bares the enzymatic activity, while the B subunit
mediates binding to the target cell membrane, trafficking
within the eukaryotic target cell and for many AB toxins,
translocation of the A subunit across cellular membranes.
Translocation never occurs across the plasma membrane.
Therefore the toxin is internalized by the cell, via pathways
that are different from one toxin to another, and transported
to a final destination, which can be early endosomes, late
endosomes, or the endoplasmic reticulum, depending again
on the toxin, from which translocation occurs. Whereas
translocation at the ER level is thought to be mediated by
the cellular translocon, transport at the level of endosomes
is mediated by the B subunit, which has pore-forming
activity [2, 61, 64]. Toxins of the AB family include
Cholera toxin, diphtheria toxin, and anthrax toxin (Table 1),
for which we will detail the mode of action because it is
most relevant to the present review.
Anthrax toxin is composed of three independent poly-
peptide chains: PA (protective antigen), EF (edema factor),
and LF (lethal factor) [2, 68]. EF is a calmodulin-dependent
adenylate cyclase thus leading to the increase in c-AMP in
intoxicated cells. LF is a metalloprotease that specifically
cleaves MAP kinase kinases such as MEK1 or MKK3.
Finally, PA corresponds to the B subunit. PA is not only
responsible for binding to the cell surface receptors, but it
also mediates binding of the enzymatic subunit, EF and LF,
transport into the endocytic pathway and translocation into
the cytoplasm. To mediate translocation, PA forms a
heptameric channel, very similar to that of pore-forming
toxins. Channel formation, however, only occurs at acidic
pH, thus requiring transport to an endosomal compartment.
Due to the ubiquitous nature of the anthrax toxin receptors,
Capillary morphogenesis gene 2 (CMG-2) [67] and Tumor
endothelial marker 8 (TEM-8) [10], most if not all cells are
sensitive to MAP kinase kinase cleavage by anthrax toxin.
However, in terms of pathogenesis, the effect on cells of the
immune system is most relevant [8]. It was in particular
shown that lethal toxin, i.e., the combination of PA and LF,
leads to impaired antigen presentation and synthesis of
stimulatory molecules by macrophages and dendritic cells,
and for certain genetic backgrounds, death, impaired activa-
tion of T cells, and inhibition of B-cell proliferation [8].
Sensing bacterial toxins
For decades, scientists have been studying the effect of
bacterial toxins on mammalian cells. The observed effects
where either directly linked to the enzymatic activity of the
toxin, such as the inhibition of neurotransmitter release in
tetanus toxin treated cells due to the toxin-mediated
proteolytic cleavage of proteins involved in synaptic vesicle
fusion (Table 1), or related to a somewhat unexplained
cellular effect, such as activation of the NF-κB pathway.
Recently, a different way of addressing the effects of toxins
has emerged, which is to investigate whether cells are able
to sense toxins, or their effects, and whether they respond to
the toxic insult [27, 29, 35, 36, 60].
Some recent studies indicate that cells can sense the effect
of certain toxins, as will be detailed below. The field is,
however, still in an embryonic state and, therefore, very few
examples will be presented. The notion of sensing toxins is of
course reminiscent of that of sensing bacterial pathogens, a
field of intense research since the discovery a decade ago that
Toll-like receptors (TLR) play an important role in innate
immunity [38]. The concept that emerged from this work is
that through out evolution from flies to mammals, organisms
produce microbial sensing proteins that recognize conserved
and often structural components of the microorganisms,
called pathogen-associated molecular patterns (PAMPs) [3].
Bacterial cell wall components such as peptidoglycan,
bacterial flagellin, and nucleic acid structures, unique to
bacteria and viruses, are examples of PAMPs. The first class
of these pattern-recognition molecules that were identified
were the TLRs, which are transmembrane proteins involved
in detection of microbes in the extracellular compartment
and in endosomes (for review, see [3]). The field of innate
immunity has become even more intense since the discovery
of a family of cytoplasmic PAMP detectors, which in
analogy to the TLRs have been termed NLRs, or Nod-like
receptors [46].
NLRs are multidomain proteins that, similar to TLRs,
contain a leucine-rich repeat (LRR) domain thought to be
involved in the sensing of PAMPs, a nucleotide-binding
and self-oligomerization domain termed NACHT domain,
and one or more effector binding domains that can be either
caspase recruitment domains (CARD) or pyrin effector
domains PYD (for review, see [45, 46, 73]). NLRs
comprise two large subclasses, the CARD-containing
nucleotide oligomerization domain or NODs (NOD1-5)
and the PYD-containing domain or Nalps (NACHT-LRR-
Semin Immunopathol (2007) 29:249–260 253
PYD-containing protein) group (Nalp1 to Nalp14). For
detailed review on NLRs, their structure, regulation, and
ligands, the reader is referred to other reviews in this issue.
As for TLRs, NLRs are thought to recognize molecular
patterns frequently encountered in microorganisms, such as
flagellin or fragments of peptidoglycan. As for TLRs,
formal evidence that binding is direct is still missing with
the exception of Nalp1, for which direct activation by
muramil dipeptide, a fragment of proteoglycan has been
reconstituted in vitro with purified molecules [19]. The
principle of NLR function is that the molecule is in an
autorepressed state, possibly through intramolecular do-
main interaction, in the absence of stimulus. Upon ligand
binding, the molecule opens up rendering the NACHT
domain accessible for homo or hetero oligomerization with
other NACHT-containing proteins and the CARD and/or
PYR domains accessible for the interaction with down
stream effectors and/or adaptor proteins. The structural
opening of the NLRs upon ligand binding thus induces the
assembly of large multiprotein complexes. The two major
documented down stream effects of NLR activation are NF-
κB activation and caspase-1 activation, events that involve
different NLR members. In this paper, we will only discuss
NLRs involved in caspase-1 activation.
The NLR containing multiprotein complexes involved in
caspase-1 activation have been termed, by Tschopp and co-
workers, the inflammasome [45]. Caspase-1 is indeed a key
player in the inflammatory response as this cystein protease is
responsible for the processing of the pro-forms of interleukins
1β 18 and 33, crucial pro-inflammatory cytokines. To date,
three different inflammasomes have been described contain-
ing Nalp1, Nalp3, and Ipaf (also a NLR family member),
respectively (see Fig. 1). Interactions of these NLRs with
caspase-1 may be either direct, as proposed for Ipaf (Fig. 1),
or require the adaptor protein ASC (Apoptosis-associated
Speck-like protein containing a CARD) [46].
As apparent above, both TLRs and NLRs are involved in
the detection of common features amongst pathogenic
organisms (peptidoglycan, flagellin, ...). As toxins, even within
a given family, differ greatly in terms of sequence and even
structure, it seems rather unlikely that either TLRs or NLRs
would detect the presence of a toxin per se. More likely, if
involved, these sensing devices should detect the consequen-
ces of the toxins action, which would be similar for toxins with
similar activities, enzymatic, or membrane impairing. We will
focus on three topics: pore-forming toxins (PFTs)—the largest
class of bacterial toxins—anthrax toxin, and finally the type III
and IV secretion systems.
Inflammasome activation by pore-forming toxins
Pore formation leads to permeabilization of the plasma
membrane to ions, and in particular to calcium and
potassium, along their electrochemical gradients, leading
to changes in cytoplasmic ion composition. The large pores
formed by certain PFTs as the cholesterol dependent toxins
LLO, SLO, and pneumolysin allow also the efflux of
cytoplasmic proteins [32, 75]. As a consequence of pore
formation by Staphylococcal α toxin, aerolysin, and LLO,
cells of the immune system such as lymphocytes or
dendritic cells were found to produce numerous inflamma-
Fig. 1 Schematic diagram of
the various inflammasome that
have been documented to as-
semble in response to bacterial
toxins or effectors of type III
secretion machineries
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tory molecules and also to undergo apoptosis [7]. The first
evidence that PFTs might activate the inflammasome was
the observation that alpha-toxin from Staphylococcus
aureus induces the release of IL-1β in LPS pretreated
monocytes [79]. In these early days, it was already
suggested that alpha-toxin triggers the activation of Inter-
leukin-converting enzyme or ICE, the former name of
caspase-1. Interestingly, these authors found that high
extracellular potassium would prevent toxin induced IL-
1β secretion, indicating the requirement for a decrease in
intracellular potassium.
More recently, it was found that aerolysin from A.
hydrophila, a toxin that shares the same mode of action as
Staphylococcal alpha toxin and makes pores of similar size
[1, 28], also triggers the activation of caspase-1 [27]. With
the increased general knowledge about caspase-1 activa-
tion, it was shown that aerolysin induced activation of
caspase-1 involves both Nalp3 and Ipaf, in a potassium
efflux dependent manner. Caspase-1 activation via the
Nalp3 pathway also required the adaptor protein ASC
(Fig. 1). Infection of primary human fibroblasts with A.
hydrophila also triggered caspase-1 activation, in contrast
to the isogenic aerolysin deficient strain [27]. In contrast,
Nalp3-dependent caspase-1 activation was still observed in
S. aureus deficient in either alpha, beta, or gamma toxin
suggesting that absence of one of the multiple PFTs
produced by this bacterium is insufficient to abrogate
caspase-1 activation [44]
Thus one of the sensing events that could be common to all
PFTs would be the decrease in cytoplasmic potassium
(changes in other ions could also be sensed, possibly by other
NLRs), which would trigger caspase-1 activation. Potassium
ionophores such as nigericin from Streptomyces hygroscopicus
[44] and valinomycin [27] have also been found to trigger
activation of caspase-1 via Nalp3 inflammasome. In vitro
studies have recently shown that NALP inflammasome
assembly and caspase-1 recruitment can actually occur
spontaneously at K+ concentrations below 90 mM [59]
Potassium efflux can also be triggered by the activation of
the purinergic P2X7 receptor by ATP, which has long been
used as a means to activate caspase-1 [58]. Activation of the
receptor-linked cation selective channel triggers a series of
events that are not fully understood. First opening of
potassium selective channels occurs, followed by the
opening of a larger pore, corresponding to the hemichannel
pannexin-1 [56]. Surprisingly, pannexin-1 was recently
shown to also be crucial for nigericin induced caspase-1
activation as well as that induced by maitotoxin [57].
Maitotoxin is a potent marine nonprotein toxin isolated from
the dinoflagellate Gambierdiscus toxicus [80] for which the
exact mode of action has not been characterized. This highly
cyclic molecule [53] (actually the largest nonprotein mole-
cule known!) first triggers an increase in cytoplasmic
calcium, followed by the opening of medium size pores that
allow the passage of <800 Da molecules, finally followed by
the formation of large “death channels.” Combined, these
studies suggest that the initial change in cytoplasmic ion
composition triggered by nigericine or maitotoxin is neces-
sary but not sufficient to trigger caspase-1 activation, which
requires pannexin-1, although apparently not through its
channel-forming activity [57]. Additional studies will be
required to clarify the role of pannexin. It will also be of
interest to test whether caspase-1 activation induced by
Staphylococcal alpha toxin and aerolysin also involves
pannexin-1.
Pannexin-1 channels are reminiscent of the PFTs that
form large pores such as SLO and listeriolysin O (LLO), in
that they allow the passage of proteins. The similarity was
recently extended by the observation that both ATP-induced
opening of pannexin-1 channels and SLO allowed the
cytosolic access of various PAMPs, such as LPS, synthetic
lipid A, lipoteichoic acid, or peptidoglycan, leading to the
activation of caspase-1 [37]. LLO was also recently found
to be implicated in the caspase-1 activation, via the Nalp3
and ASC inflammasome by L. monocytogenes [44, 54]. L.
monocytogenes is a Gram-positive facultative intracellular
pathogen that can cause life-threatening infections in
neonates and immunocompromised hosts. The bacterium
enters into cells via a clathrin-mediated pathway [78] and
then escapes into the cytoplasm through LLO mediated
rupture of the phagosomal membrane [16]. Macrophages
cultured with L. monocytogenes deficient in LLO failed to
secrete IL-1β [44, 54]. It is however not clear at what step
LLO pore formation was involved in caspase-1 activation:
pore formation in the plasma membrane, as recently
suggested [71] or in the phagosome? Was cytoplasmic
release of the bacterium the required event? In other words,
was inflammasome assembly triggered by changes in ion
composition or by the presence of PAMPs or both?
Involvement of NLRs in sensing and responding
to anthrax toxin
The second toxin to which cells seem to respond in an
inflammasome dependent manner is anthrax toxin. Macro-
phages treated with anthrax lethal toxin were found to
secrete IL-1β and IL-18 [9, 15]. Direct evidence for the
lethal toxin induced activation of caspase-1 was recently
obtained by Boyden and Dietrich and confirmed by others
([51], Reig et al., submitted). Searching for an anthrax
susceptibility gene in mouse macrophages, Boyden and
Dietrich found that Nalp1b was involved in lethal toxin
induced cell death in mouse macrophages, in a genetic
background dependent manner. These authors found that
the gene encoding for Nalp1b is highly polymorphic, with 5
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alleles identified among 18 mice strains. Allele 1, found for
example in Balb/cJ, C3H/HeJ, and 129S1/svImJ mice, was
found to encode a Nalp1b protein (termed type 1 Nalp1b)
that was able to mediate caspase-1 activation in response to
lethal toxin. In contrast, allele 2, found in C57B6 mice, and
allele 4, found in DBA/2J mice, encodes a Nalp1b protein
that is unable to activate caspase-1 in response to LT
(termed type 2 Nalp1b). Whether ASC is required for the
type 1 Nalp1b mediated activation of caspase-1 requires
further investigation.
The mechanisms that leads to activation of Nalp1b in
response to lethal toxin are unclear. It is unlikely, at least
for two reasons, that the lethal factor is itself recognized by
Nalp1b as a PAMP. As mentioned previously, considering
the diversity of bacterial proteins that reach the cytoplasm,
it is unlikely that there would be proteins to sense them, the
number of sensing proteins would have to be too great.
Secondly, the catalytic activity of lethal factor is required to
trigger caspase-1 activation, as a translocation competent
but catalytically inactive LF was unable to trigger caspase-1
activation, despite its delivery to the cytoplasm (Reig et al.,
submitted). Sensing thus appears to occur down stream of
MAPK kinase cleavage by LF. Determining the sensed
events or component will be of great interest.
Bacterial secretion machineries and the inflammasome
A variety of Gram-negative bacteria, such as Salmonella and
Shigella, that enter and multiply within cells absolutely
require their T3SSs for invasion. Upon infection of macro-
phages, both these bacteria induce robust caspase-1 activa-
tion, which leads to the release of IL-1β and IL-18 followed
by caspase-1 mediated death [12, 31, 34, 65, 77]. The
proteins Salmonella SipB and Shigella IpaB, which mediate
puncturing of the host cell membrane upon Salmonella and
Shigella invasion, respectively, seem to have a direct role in
caspase-1 induced cell death as microinjection of recombinant
SipB or IpaB protein is sufficient to induce apoptosis in
macrophages [13, 31]. Furthermore, Salmonella and Shigella
strains defective in IpaB or SipB do not induce macrophage
apoptosis [31, 34]. Although direct binding of IpaB and SipB
was thought to activate caspase-1 [31, 34], more recent data
suggest that SipB has a more indirect role in caspase-1
activation during infection with Salmonella sp. [22, 47].
Since in the absence of these proteins, none of the other
effectors can reach the cytosol, it is unclear whether
inflammasome activation is triggered by the secretion system,
or some of the effectors, or PAMPs that gain access through
IpaB or SipB channels. It was recently shown that the
hydrophobic translocators of Yersinia, YopB and YopD,
induce caspase-1 activation and IL-1β secretion upon
infection with strains that are deficient in effectors [69].
These observations highlight the importance of membrane
impairment in triggering inflammation. Interestingly upon
infection with a Yersinia wild type strain, caspase-1 activation
did not occur, suggesting that the effectors neutralize the pro-
inflammatory phenomenon of the translocator either by
inhibiting caspase-1 activation through the GTPase activity
of the effector protein YopE (Schotte, Denecker et al. 2004)
or possibly by clogging the translocon [69].
Infection by S. typhymurium and S. flexneri, however,
appears to trigger the activation of more than one type of
inflammasome as both ASC and Ipaf were found to be
involved in activating caspase-1 [43]. Only the Ipaf
inflammasome was, however, essential for caspase-1
dependent cell death [42]. Although still requiring SipB,
S. typhimurium flagellin was found to trigger Ipaf mediated
caspase-1 activation as flagellin deficient Salmonella did
not activate caspase-1 [22, 47, 62]. Furthermore, Ipaf
activation could be recapitulated by the introduction of
purified flagellin directly in the cytoplasm. Altogether,
these studies indicate that bacteria may trigger caspase-1
activation via more than one pathway.
Activation of caspase-1 has also been observed for other
Gram-negative such as the facultative intracellular pathogen
Burkholderia pseudomallei, which harbors a T3SS highly
homologous to that of S. typhymurium and S. flexneri. B.
pseudomallei is the causative agent for meliodosis, an
infection that results in a wide spectrum of clinical
outcomes including asymptomatic, acute or chronic pneu-
monia, or septicemia [11]. B. pseudomallei infected macro-
phages where found to undergo caspase-1 dependent cell
death. The inflammasome components mediating cell death
were however not determined, nor was the role of BipB, the
Burkholderia homologue of IpaB.
Finally, Legionella pneumophila, a T4SS harboring
Gram-negative intracellular pathogen was also found to
trigger caspase-1 activation [82]. Activation was strictly
dependent of Dot-Icm type IV secretion system and led to
the assembly of two NLR containing complexes: a Birc1e
(Naip5) and an Ipaf inflammasome that were sensitive to
bacterial flagellin [5, 62].
Interplay between TLRs and inflammasomes
Activated caspase-1 is essential for the processing and release
of biologically active IL-1β and IL-18, two proinflammatory
cytokines with critical roles in innate and adaptive immunity
[17]. The secretion of IL-1β is also dependent on the levels
of pro-IL-1β induced at the transcriptional level by pro-
inflammatory stimuli including several TLR ligands such as
lipopolysaccharide (LPS), lipoteichoic acid (LTA), CpG
oligonucleotides, the antiviral compound resiquimod R848,
and the lipopeptide Pam3CSK4 [41]. The crucial signal
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transduced by TLRs for the induction of pro-IL-1β expres-
sion is likely mediated by the transcription factor NF-κB. The
cytokine IL-18 is also synthesized as an inactive precursor,
but, unlike pro-IL-1β, it is expressed constitutively. Despite
the importance of TLR activation in pro-IL-1β synthesis, the
relationship between TRL and inflammasome signaling
remains poorly understood.
Several lines of evidence indicate that caspase-1 activation
does not depend on TLR signaling. It has indeed been shown
that inhibition of TLR signaling, for example, upon knock out
of MyD88 or Toll/IL-1 receptor (TIR)-domain-containing
adaptor-inducing IFN-β (TRIF), two adaptor molecules that
are critical for TLR mediated NF-κB activation, up-regulation
of pro-IL-1β does not occur but processing of caspase-1 is
unaltered [37, 54, 81]. In contrast, recent data now indicate
that TLR signaling can be regulated by caspase-1. Upon
ligand activation of TLRs, cytosolic TIR domain-containing
adapter proteins are recruited to initiate signaling events [48].
Among them, the MyD88 adaptor-like (MAL) protein is
required for signaling by the LPS receptor TLR4 and the
bacterial lipoprotein receptor TLR2 and acts as a bridging
adapter for MyD88 recruitment [48]. Recent results reveal
that MAL requires cleavage by caspase-1 to elicit its
downstream signal NF-κB [49]. Consequently, signaling by
TLR2 and TLR4 is impaired in caspase-1 deficient cells. NF-
κB activation via Receptor Interacting Protein-2 (RIP2) was
also found to involve caspase-1 [66]. In this case also, NF-κB
activation by LPS was attenuated in caspase-1 deficient
macrophages and was inhibited by a catalytically inactive
form of caspase-1. Furthermore, the authors point out a
possible regulatory role of ASC in the communication
between the inflammasome and the NF-κB pathway. Over-
expression of ASC led to a decrease in NF-κB activity,
whereas ASC knock down led to an increase in NF-κB
activity suggesting an inhibitory role of ASC in NF-κB
signaling. These findings shed light on an important
mechanism for the coordinated activation of host defense
responses by TLRs and the inflammasome.
At present, there is no evidence that toxins trigger TLRs.
Il-1β secretion upon exposure to pore-forming toxins or
anthrax toxin might be due to the synergistic effect of
bacterial PAMPs and the toxins. Cellular damage due to
bacterial toxins, in particular, PFTs, could also lead to the
release of endogenous TLR ligands such as heat shock
proteins [76] or other danger signals.
Consequences of toxins induced caspase-1 activation
The consequences of toxin-induced caspase-1 activation
appear to be strongly cell type dependent. In cells of the
immune system such as macrophages, the most striking
consequence of caspase-1 activation by either the pore-
forming effectors of T3SS harboring bacteria or the totally
unrelated anthrax toxin is cell death, in addition to processing
and secretion of IL-1β and IL-18 [9, 13, 31, 33]. The
underlying mechanisms, however, remain completely obscure
and probably involve yet to be identified targets of caspase-1
(Fig. 2). Caspases-2, 3, and 11 do not seem to be involved in
this process, and Bcl-2 overexpression does not block
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Shigella-induced cell death in macrophages [34]. Several
lines of evidence suggest that caspase-1 induced cell death is
mechanistically distinct from the forms of classical apoptosis
and was therefore termed pyroptosis [20]. An interesting
event described in pyroptosis is the caspase-1 dependant
formation of plasma membrane pores, between 1.1 and
2.4 nm in diameter, that appear concurrently to the release
of processed IL-1β and IL-18 and precede cell death [21].
These pores also dissipate ionic gradients leading to water
uptake and cell swelling, ultimately culminating in osmotic
lysis with release of inflammatory cellular contents. Despite
of their difference in size, these membrane pores are
reminiscent of the pannexin-1 pore mentioned above [56].
An interesting aspect of caspase-1 mediated cell death in
response to anthrax lethal toxin, and presumably others to
come, is that cell death is not a direct consequence of the
toxins action, as illustrated by the fact that nonimmune cells
survive toxin action for days (unpublished observations).
Rather, death of immune cells is due to the innate response
of the cells to the action of the toxin. This theme is
reminiscent of what has been observed in infection where
tissue damage is often the results of a massive immune
response rather that the action of the bacterium itself.
Many toxins however target nonimmune cells such as
epithelial cells. This is in particular the case for the pore-
forming toxin aerolysin produced by the enteropathogen A.
hydrophila. Aerolysin was shown to trigger caspase-1
activation both in fibroblast like cells [27] as well as human
intestinal cells (Freche and van der Goot, unpublished). These
cells express low to undetectable level of Il-1β and thus
caspase-1 does not appear to mediate cytokine secretion.
These cells are however sensitive to caspase-1 activation. We
have recently shown that caspase-1 triggers the activation of
the central regulators of lipid metabolism, the sterol respon-
sive element binding proteins (SREBPs) after treatment of
epithelial cells with aerolysin and Staphylococcal α toxin
[27]. SREBPs are membrane-bound transcription factors that
control the synthesis of enzymes involved in lipid metabolism
[26]. Caspase-1 mediated SREBP activation was found to
promote cell survival after toxin attack. Although SREBP
activation occurs via a proteolytic mechanism, cleavage
required the traditional site-1 and site 2-protease indicating
that caspase-1 was processing a yet to be identified substrate
involved up stream of SREBP.
Concluding remarks
The exquisite action of bacterial toxins on cellular functions
of the target cells is a consequence of a long tem
coevolution between bacteria and host. But evolution has
not only shaped the pathogen but clearly also the host and
recent reemergence of the innate immunity field has
provided beautiful examples of how hosts detect the
presence of pathogens through the present of particular
patterns. Toxins however appear to be detected through
their effects rather than by their structure, which are
extremely diverse and show not conserved patterns. The
coming years are likely to be exciting as sensors for the
effect of toxins will be identified and understood.
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